AGP Picks
View all

Tech News Iraq
Provided by AGP

Tech News Iraq: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News Iraq.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 18, 2026

Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean
May 18, 2026

Digital Realty Opens First Data Center in Barcelona, Strengthening Its Position Across the Mediterranean

Indeterminate GlobeNewswire
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 18, 2026

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development
May 18, 2026

Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development

Indeterminate GlobeNewswire
Enhanced (NYSE: ENHA) Selects Rezolve Ai (NASDAQ: RZLV) to Power AI-Native Live Enhanced Consumer Platform and Digital Fan Ecosystem
May 18, 2026

Enhanced (NYSE: ENHA) Selects Rezolve Ai (NASDAQ: RZLV) to Power AI-Native Live Enhanced Consumer Platform and Digital Fan Ecosystem

Indeterminate GlobeNewswire
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
May 18, 2026

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Indeterminate GlobeNewswire
BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET
May 18, 2026

BIO-key Q1 Bottom-Line Improves on 34% Rise in Revenue; Expects Q2 Profitability on 65% Revenue Increase; Investor Call Today at 10am ET

Indeterminate GlobeNewswire
Core AI Holdings Reports Record 59% Revenue Growth and Strategic AI Expansion
May 18, 2026

Core AI Holdings Reports Record 59% Revenue Growth and Strategic AI Expansion

Indeterminate GlobeNewswire
Duos Technologies Reports First Quarter 2026 Results
May 18, 2026

Duos Technologies Reports First Quarter 2026 Results

Indeterminate GlobeNewswire
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
May 18, 2026

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Indeterminate GlobeNewswire
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
May 18, 2026

Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale

Indeterminate GlobeNewswire
Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications
May 18, 2026

Kraig Biocraft Laboratories Announces Breakthrough Creation of Immortalized Silkworm Silk Gland Cell Line with Broad Biotechnology Applications

Indeterminate GlobeNewswire
Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development
May 18, 2026

Byondis Establishes Scientific Advisory Board of Recognized Leaders in Oncology Research and ADC Development

Indeterminate GlobeNewswire
Quantum Cyber to Exhibit at Special Operations Forces Week 2026
May 18, 2026

Quantum Cyber to Exhibit at Special Operations Forces Week 2026

Indeterminate GlobeNewswire
Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board
May 18, 2026

Juniper Biosciences Appoints Renowned Radiopharmaceutical Expert Jason S. Lewis, Ph.D. as Chair of Newly Formed Scientific Advisory Board

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 18, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Denodo Advances Trusted Data Foundations for Agentic AI with New Amazon Web Services (AWS) Integrations
May 18, 2026

Denodo Advances Trusted Data Foundations for Agentic AI with New Amazon Web Services (AWS) Integrations

Indeterminate GlobeNewswire
Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas
May 18, 2026

Regeneron Announces Strategic Collaboration with Parabilis Medicines to Advance Novel Antibody-Helicon™ Conjugates Across Multiple Therapeutic Areas

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Tech News Iraq

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.